Strategic Financial Concepts LLC acquired a new position in shares of Colgate-Palmolive (NYSE:CL – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 167,953 shares of the company’s stock, valued at approximately $15,269,000.
Other institutional investors also recently made changes to their positions in the company. Union Bancaire Privee UBP SA bought a new stake in shares of Colgate-Palmolive during the fourth quarter worth approximately $32,000. Hager Investment Management Services LLC bought a new stake in shares of Colgate-Palmolive during the fourth quarter worth approximately $36,000. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the third quarter worth approximately $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive in the third quarter valued at approximately $53,000. Finally, Synergy Asset Management LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $49,000. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Price Performance
CL stock opened at $86.81 on Friday. The stock has a market capitalization of $70.93 billion, a PE ratio of 24.66, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44. The company’s 50-day moving average is $90.56 and its 200-day moving average is $96.84. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26. Colgate-Palmolive has a 1 year low of $82.68 and a 1 year high of $109.30.
Colgate-Palmolive Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.30%. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.
Analyst Ratings Changes
Several equities research analysts recently issued reports on the company. UBS Group cut their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Wells Fargo & Company lowered their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Raymond James restated an “outperform” rating and set a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Piper Sandler lowered their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Finally, Stifel Nicolaus lowered their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus target price of $101.16.
Check Out Our Latest Report on CL
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- What is the NASDAQ Stock Exchange?
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Best Stocks Under $10.00
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- What Are Dividend Contenders? Investing in Dividend Contenders
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.